Global Lung Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • ID: 4471500
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbvie
  • Bayer
  • Celgene
  • Eli Lilly And CoMPany
  • Merck & Co. Inc.
  • Pharmacyclics
  • MORE
The global lung cancer diagnosis market is anticipated to grow at a CAGR of 7.4% by 2023. Lung cancer occurs when cells of the lung become abnormal and begin to grow out of control. As more cancer cells develop, they form into a tumor and spread to other areas of the body. There are two types of lung cancer; Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC). Several factors such as pollution, smoking, passive smoking and other factors cause lunch cancer. There are several factors that are being considered for the cause of the lung cancer such as rising pollution due to the amount of carbon particles inhaled by humans. Robust healthcare expenditure within the developed countries, increasing pollution, Government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the growth of the market. Several signs and symptoms of lung cancer include coughing up blood, weight loss, chest pain, shortness of breath and others.

The lung cancer diagnosis and therapeutics market has been segmented into by type, by treatment, by diagnosis, by stages, and by end user. On the basis type, the market has been bifurcated into non-small cell lung cancer and small cell lung cancer. According to therapy, the market has been bifurcated into chemotherapy, targeted therapy, immunotherapy, radiation therapy and others. Based on diagnosis, the market has been bifurcated into CT-scan, X-rays, lung cancer screening, needle biopsy, bronchoscopy, sputum cytology and others On the basis of end user, the market has been bifurcated into multispecialty hospitals and cancer research centers.

Geographically, the worldwide lung cancer diagnosis and therapeutics showcase is divided into North America, Europe, Asia-Pacific, and Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cancer patients in the APAC region is considered to rise eventually enabling the lung cancer diagnosis and therapeutics market to grow. The North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in technology, support from government, rising key players and other factors.

The key players in the lung cancer diagnosis and therapeutics market include Astrazeneca plc, Eli lilly and Sanofi-Aventis, Arqule Inc, Daiichi Sankyo co. Ltd, Celgene, Merck, Pfizer, Ventana, Roche, Genentech, Glaxosmith, Boehringer, Novartis, Bayer, Bristol-Myers Squibb, Eisai, AbbVie, Pharmacyclics.

Market Segmentation:

Global lung cancer diagnosis and therapeutics market is segmented on the basis of, type, by therapies, by diagnosis, by end user and regional outlook.
  • Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type
  • Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapies
  • Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis
  • Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User
  • Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Region
The Reports Covers:
  • Comprehensive research methodology of global lung cancer diagnosis and therapeutics
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global lung cancer diagnosis and therapeutics
  • Insights about market determinants which are stimulating the global lung cancer diagnosis and therapeutics
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbvie
  • Bayer
  • Celgene
  • Eli Lilly And CoMPany
  • Merck & Co. Inc.
  • Pharmacyclics
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Rising Incidence of Lung Cancer
3.1.2. Rising Utilization of Combine Therapies for Treatment of Lung Cancer
3.1.3. Government Initiatives to Increase Awareness for Lung Cancer
3.1.4. Rising Pollution Due to Urbanization Increases Symptons of Lung Cancer
3.2. Restraints
3.2.1. High Cost Associated With Therapies
3.2.2. Adverse Effects of Drugs During Treatment
3.3. Opportunities
3.3.1. R&D in Mixed Therapies
3.3.2. Strategic Alliance for Late-Stage Pipeline

4. Market Segmentation
4.1. Global Lung Cancer Diagnosis and Therapeutics Market, by Type
4.1.1. Non-Small Cell Lung Cancer
4.1.1.1. Adenocarcinomas
4.1.1.2. Bronchioloalveolar Carcinoma
4.1.1.3. Squampous Cell Carcinoma
4.1.1.4. Large Cell Carcinomas
4.1.2. Small Cell Lung Cancer
4.2. Global Lung Cancer Diagnosis and Therapeutics Market, by Therapy
4.2.1. Chemotherapy
4.2.2. Targeted Therapy
4.2.3. Immunotherapy
4.2.4. Radiation Therapy
4.2.5. Others
4.3. Global Lung Cancer Diagnosis and Therapeutics Market, by Diagnosis
4.3.1. CT Scan
4.3.2. X-Rays
4.3.3. Lung Cancer Screening
4.3.4. Needle Biopsy
4.3.5. Bronchoscopy
4.3.6. Sputum Cytology
4.3.7. Others
4.4. Global Lung Cancer Diagnosis and Therapeutics Market, by End User
4.4.1. Multispeciality Hospitals
4.4.2. Cancer Research Centers

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Abbvie
7.2. Arqule Inc.
7.3. Astrazeneca PLC
7.4. Bayer
7.5. Boehringer .
7.6. Bristol-Myers Squibb
7.7. Celgene
7.8. Daiichi Sankyo Co. Ltd.
7.9. Eisai
7.10. Eli Lilly and Company
7.11. Genentech
7.12. Glaxosmith
7.13. Merck & Co. Inc.
7.14. Nov
7.15. Pfizer
7.16. Qiagen N.V. Company
7.17. Pharmacyclics
7.18. Roche
7.19. Sanofi
7.20. Teva Pharmaceuticals
7.21. Ventana
7.22. Valeant Pharmaceuticals Inc.
7.23. Varian Medical Systems Inc.

List of Tables:
Table 1 Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Geography, 2017-2023,
Table 2 Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($ Million)
Table 3 Global Non-Small Cell Lung Cancer Market Research and Analysis, 2017-2023, ($ Million)
Table 4 Global Adenocarcinomas Market Research and Analysis, 2017-2023, ($ Million)
Table 5 Global Bronchioloalveolar Carcinoma Market Research and Analysis, 2017-2023, ($ Million)
Table 6 Global Sarcomas Cell Carcinoma Market Research and Analysis, 2017-2023, ($ Million)
Table 7 Global Large Cell Carcinoma Market Research and Analysis, 2017-2023, ($ Million)
Table 8 Global Small Cell Lung Cancer Market Research and Analysis, 2017-2023, ($ Million)
Table 9 Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($ Million)
Table 10 Global Chemotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 11 Global Targeted Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 12 Global Immunotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 13 Global Radiotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 14 Global Other Market Research and Analysis, 2017-2023, ($ Million)
Table 15 Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis, 2017-2023, ($ Million)
Table 16 Global Ct-Scan Market Research and Analysis, 2017-2023, ($ Million)
Table 17 Global X-Rays Market Research and Analysis, 2017-2023, ($ Million)
Table 18 Global Lung Cancer Screening Market Research and Analysis, 2017-2023, ($ Million)
Table 19 Global Needle Biopsy Market Research and Analysis, 2017-2023, ($ Million)
Table 20 Global Bronchoscopy Market Research and Analysis, 2017-2023, ($ Million)
Table 21 Global Sputum Cytology Market Research and Analysis, 2017-2023, ($ Million)
Table 22 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 23 Global Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023, ($ Million)
Table 24 Global Multispecialty Hospitals Market Research and Analysis, 2017-2023, ($ Million)
Table 25 Global Cancer Research Institute Market Research and Analysis, 2017-2023, ($ Million)
Table 26 Merger and Acquisition
Table 27 Global Lung Cancer Diagnosis and Therapeutics Market, by Geography 2016-20122($ Million)
Table 28 North America Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 29 North America Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 30 North America Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 31 North America Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 32 North America Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 33 Europe Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 34 Europe Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 35 Europe Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 36 Europe Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 37 Europe Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 38 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 39 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 40 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 41 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 42 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 43 Rest of the World Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 44 Rest of the Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 45 Rest of the World Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 46 Rest of the World Lung Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)Figure 1 Global Lung Cancer Diagnosis and Therapeutics Market Share, by Type 2017 and 2023, (In %)
Figure 2 Global Lung Cancer Diagnosis and Therapeutics Market Share, by Therapy 2017 and 2023, (In %)
Figure 3 Global Lung Cancer Diagnosis and Therapeutics Market Share, by Diagnosis 2017 and 2023, (In %)
Figure 4 Global Lung Cancer Diagnosis and Therapeutics Market Share, by End Users 2017 and 2023, (In %)
Figure 5 Global Lung Cancer Diagnosis and Therapeutics Market Share, by Geography 2017 and 2023, (In %)
Figure 6 North American Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 7 US Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 8 Canada Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 9 European Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 10 UK Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 11 France Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 12 Germany Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 13 Italy Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 14 Spain Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 15 ROE Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 16 Asia Pacific Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 17 India Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 18 China Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 19 Japan Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 20 RoAPAC Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 21 Rest of the World Lung Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbvie
  • Arqule Inc.
  • Astrazeneca Plc
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Daiichi Sankyo Co. Ltd.
  • Eisai
  • Eli Lilly And CoMPany
  • Genentech
  • Glaxosmith
  • Merck & Co. Inc.
  • Nov
  • Pfizer
  • Qiagen N.V. CoMPany
  • Pharmacyclics
  • Roche
  • Sanofi
  • Teva Pharmaceuticals
  • Ventana
  • Valeant Pharmaceuticals Inc.
  • Varian Medical Systems Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll